top of page

Ron Rocca

President & Chief Executive Officer, Mindera Health

Mr. Rocca brings more than two decades of biotech, pharma and diagnostics industry experience, including 11 years of developing and commercializing diagnostic products for autoimmune-related diseases. He currently serves as president and chief executive officer of Mindera Health. His prior role was president and CEO of Exagen Inc. (NASDAQ: XGN), which commercialized a suite of testing products enabling healthcare providers to improve care for patients through the differential diagnosis and prognosis. Prior to Exagen, Mr. Rocca served as GM, at Prometheus Laboratories, Inc., a specialty pharmaceutical and diagnostic company focused on diseases in gastroenterology and oncology. Earlier in his career, Mr. Rocca served in senior sales and marketing management positions for Elan Pharmaceuticals. Mr. Rocca received a BA in marketing and personnel management from Towson University. In addition to serving on the board of Circular Genomics, Mr. Rocca also is a board member at Interpace Diagnostics.

Ron Rocca
bottom of page